GLP-1 RA use was also tied to lower rates of immune-related side effects, caused by the immune system becoming overactive as a result of immunotherapy treatment. Patients taking GLP-1 drugs showed ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related cancers, namely lung, breast, colorectal, and liver cancers. In addition, GLP-1 ...

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...

Weight-loss jabs can reduce the risk of cancer and stop it from becoming incurable, research has suggested. A study has found ...

A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic ...

Cuomo notes that while these results are observational, they underscore an urgent need for clinical trials to test whether GLP-1 drugs can improve cancer survival rates, especially for patients with ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...

University of Pennsylvania researchers say an analysis of more than 110,000 women ages 45-80 revealed GLP-1 users were 30 ...

Weight loss drugs were linked to a major shift in cancer survival in a new study.

Please provide your email address to receive an email when new articles are posted on . Among patients with diabetes, those taking a GLP-1 had better 3-year survival rates after PCI for a heart attack ...

More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, ...